Bioavailability of two licensed paediatric rifampicin suspensions: implications for quality control programmes.
McIlleron H, Hundt H, Smythe W, Bekker A, Winckler J, van der Laan L, Smith P, Zar HJ, Hesseling AC, Maartens G, Wiesner L, van Rie A.
McIlleron H, et al. Among authors: bekker a.
Int J Tuberc Lung Dis. 2016 Jul;20(7):915-9. doi: 10.5588/ijtld.15.0833.
Int J Tuberc Lung Dis. 2016.
PMID: 27287644
Free PMC article.
Clinical Trial.